Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome

Eur Neurol. 1998;39(4):234-7. doi: 10.1159/000007940.

Abstract

We investigated the exact prevalence of dementia of Alzheimer type (DAT) and apolipoprotein E (ApoE) phenotypes in 106 Japanese Down's syndrome (DS) patients. Among these patients 16 were diagnosed as having DAT. The prevalence of DAT was 0% in the 30- to 39-year-old group, 16% in the 40- to 49-year-old group, and 38% in those over 50 years old. The frequency of the epsilon4 allele in DS patients with DAT was 18.8%, which was considerably higher than that of nondemented DS patients (4.5%) and Japanese nondemented controls (6.7%). Especially, the frequency of the epsilon4 allele in DS patients who developed DAT under 50 years was significantly higher (28.6%). DS patients certainly develop DAT at earlier ages but the prevalence of DAT in each group of patients was lower than previously recognized. It is very likely that the ApoE epsilon4 is a risk factor for DAT even in DS patients with a genetic predisposition to Alzheimer's disease.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics
  • Apolipoproteins E / genetics*
  • Down Syndrome / genetics*
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Phenotype
  • Prevalence

Substances

  • Apolipoproteins E